Skip to content
cccskills
FreePublished on GitHub

endo-csii-continue-hospital-if-protocols

Suggests that clinicians continue CSII in hospitalized patients with type 1 or type 2 diabetes when the institution has clear protocols for evaluating pump candidates and appropriate monitoring and safety procedures. Trigger phrases include: 'Admitted patient on pump, check hospital pump policy' and 'Inpatient with diabetes using pump, verify institutional guidelines'.

The English summary is being prepared. Showing the original description.

See how to install

Files included (1)

  • SKILL.md2.4 KB

SKILL.md (original)

Review the instructions the agent will receive before you install.

Suggest continuing CSII in hospital if protocols exist

STEP 1 — Gather Information

Confirm hospitalization, diabetes type (T1DM or T2DM), current home CSII use, and whether the hospital has a written protocol for evaluating insulin pump candidates and for monitoring/safety during inpatient stay.

STEP 2 — Rule In / Rule Out

Is there an institutional protocol for evaluating CSII candidates and appropriate monitoring/safety? If yes, proceed to Step 3; if no, recommend discontinuing CSII and transitioning to basal-bolus insulin infusion (or MDI) per inpatient glycemic management guidelines.

STEP 3 — Classify or Stratify

Assess patient suitability using the hospital’s pump criteria: ability to self-manage pump, no contraindications (e.g., DKA risk, altered mental status, NPO without pump plan), and availability of nursing support familiar with pump therapy. Classify as suitable or unsuitable.

STEP 4 — Decide

If suitable and protocols exist, continue CSII with frequent glucose monitoring (pre-meal, bedtime, and as needed) and adjust basal/bolus per protocol; if unsuitable, discontinue pump and initiate scheduled basal-bolus insulin or insulin infusion per hospital order sets.

Clinical Guardrails / Mimics / Pitfalls

Do not continue CSII if the patient cannot operate the pump, is NPO without a plan for pump management, has recurrent hypoglycemia unawareness, or if nursing staff lack pump training; avoid assuming continuation without verifying institutional policy to prevent medication errors and safety events.

Concrete Clinical Example

A 62-year-old man with type 1 diabetes admitted for bowel resection uses an insulin pump at home; the hospital has a pump policy, he is alert and capable, and nursing is trained; his pump is continued with glucose checks every 4 hours and basal rates adjusted per surgical stress.

Source: Insulin pump use in the hospital, Endocrine Society Clinical Practice Guideline, 2016, DOI:10.1210/jc.2016-2534

Reviews

No reviews yet. Tell others what you thought.

Comments

No login needed. Share how it worked for you, ask a question, or note where it did not run.

No comments yet. Be the first to write one.

Comments are published right away. Do not include personal information such as email addresses or phone numbers. Up to 2 URLs.

0 / 1,000 characters

This form is protected by reCAPTCHA, and the Google Privacy Policy and Terms of Service apply.

More skills from this repository

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

See all skills by dromlakhani

Report a problem with this skill